Related references
Note: Only part of the references are listed.ADAMTS9 Is a Cell-Autonomously Acting, Anti-Angiogenic Metalloprotease Expressed by Microvascular Endothelial Cells
Bon-Hun Koo et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
ADAMTS-2 functions as anti-angiogenic and anti-tumoral molecule independently of its catalytic activity
J. Dubail et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
MEROPS: the peptidase database
Neil D. Rawlings et al.
NUCLEIC ACIDS RESEARCH (2010)
Characterization of proADAMTS5 processing by proprotein convertases
Jean-Michel Longpre et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
Cleavage of syndecan-4 by ADAMTS1 provokes defects in adhesion
Juan Carlos Rodriguez-Manzaneque et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
The first but not the second thrombospondin type 1 repeat of ADAMTS5 functions as an angiogenesis inhibitor
Soheila Sharghi-Namini et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
The ADAMTS12 metalloproteinase exhibits anti-tumorigenic properties through modulation of the Ras-dependent ERK signalling pathway
Maria Llamazares et al.
JOURNAL OF CELL SCIENCE (2007)
Anti-angiogenic peptides identified in thrombospondin type I domains
Emmanouil D. Karagiannis et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Neuropilins in physiological and pathological angiogenesis
C. A. Staton et al.
JOURNAL OF PATHOLOGY (2007)
ADAMTS1 mediates the release of antiangiogenic polypeptides from TSP1 and 2
Nathan V. Lee et al.
EMBO JOURNAL (2006)
Changes in immunolocalisation of β-dystroglycan and specific degradative enzymes in the osteoarthritic synovium
S. Wimsey et al.
OSTEOARTHRITIS AND CARTILAGE (2006)
Vascular endothelial growth factor signaling pathways: Therapeutic perspective
Marcin Kowanetz et al.
CLINICAL CANCER RESEARCH (2006)
VEGF receptor signalling - in control of vascular function
AK Olsson et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
ADAMTS proteinases: a multi-domain, multi-functional family with roles in extracellular matrix turnover and arthritis
GC Jones et al.
ARTHRITIS RESEARCH & THERAPY (2005)
A high-throughput cell migration assay using scratch wound healing, a comparison of image-based readout methods
JC Yarrow et al.
BMC BIOTECHNOLOGY (2004)
Thrombospondin modules and angiogenesis
ML Iruela-Arispe et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2004)
ADAMTS1/METH1 inhibits endothelial cell proliferation by direct binding and sequestration of VEGF165
A Luque et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The utility of Ki-67 and BrdU as proliferative markers of adult neurogenesis
N Kee et al.
JOURNAL OF NEUROSCIENCE METHODS (2002)
Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms
I Stalmans et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth
J Lawler
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2002)
Saccharomyces cerevisiae commits to a programmed cell death process in response to acetic acid
P Ludovico et al.
MICROBIOLOGY-SGM (2001)
Brevican is degraded by matrix metalloproteinases and aggrecanase-1 (ADAMTS4) at different sites
H Nakamura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Gene expression profiling in an in vitro model of angiogenesis
J Kahn et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)